In addition, the potential effects of the treatment on anxiety or exploration were discarded, as no significant differences were observed between the AAV control and AAV-nectin-3-treated rats in the open field (OF) and novel object (NO) reactivity tests (Supplementary Fig. 3c,d). The gene discussed is NECTIN3; the disease is Anxiety.